Apr 4, 2022
|
Ardelyx Announces US Launch of IBSRELA®, a New First-in-Class Treatment for IBS-C in Adults
|
Mar 9, 2022
|
Ardelyx, Inc. Reports Employment Inducement Grants
|
Mar 2, 2022
|
Ardelyx to Participate at the Cowen 42nd Annual Health Care Conference
|
Feb 28, 2022
|
Ardelyx Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights
|
Feb 24, 2022
|
Ardelyx Announces $27.5 Million Debt Financing Agreement with SLR Capital Partners
|
Feb 22, 2022
|
Ardelyx to Report Fourth Quarter and Year-End 2021 Financial Results and Provide Corporate Update on February 28, 2022
|
Feb 4, 2022
|
Ardelyx, Inc. Reports Employment Inducement Grants
|
Nov 30, 2021
|
Ardelyx Launching IBSRELA® Second Quarter of 2022
|
Nov 12, 2021
|
Ardelyx Reports Third Quarter 2021 Financial Results
|
Nov 11, 2021
|
Ardelyx to Present at the Jefferies London Healthcare Conference
|